GlassScriptPhysician profile
Aubrie Chiu
NPI 1205526159
$1,592.00
in general payments reported to CMS, 2019-2025
18 companies · $727 in 2025
The $727 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $865 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,032 · Education: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,032.07 |
| Education | $559.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $322.96 | 2024-2025 | Trodelvy |
| Astellas Pharma US INC | $224.79 | 2024-2025 | Vyloy, Padcev |
| Abbvie INC. | $181.16 | 2024-2025 | |
| Pfizer INC. | $145.88 | 2024-2025 | |
| Daiichi Sankyo INC. | $127.96 | 2024-2025 | Enhertu, Vanflyta |
| Seagen INC. | $99.95 | 2024 | |
| Tempus Ai, INC | $96.76 | 2025 | Xt Cdx |
| Merck Sharp & Dohme LLC | $78.61 | 2024-2025 | Keytruda |
| Alexion Pharmaceuticals, INC. | $76.36 | 2024-2025 | Ultomiris |
| Emd Serono, INC. | $43.15 | 2024 | |
| Lilly USA, LLC | $33.76 | 2024 | Verzenio, Jaypirca, Retevmo |
| Janssen Biotech, INC. | $29.76 | 2024 | Rybrevant |
| Jazz Pharmaceuticals INC. | $29.46 | 2024 | |
| Novartis Pharmaceuticals Corporation | $22.80 | 2025 | |
| Genzyme Corporation | $22.71 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $20.17 | 2024 | Ojjaara |
| Btg International INC. | $18.80 | 2024 | |
| Cumberland Pharmaceuticals, INC. | $16.96 | 2024 | Sancuso |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aubrie Chiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.